Biopharmaceutical Research Company Will Be Among First in the Nation to Receive a License for Federal Cannabis Production

CALIFORNIA: Biopharmaceutical Research Company (BRC), a specialty pharmaceutical manufacturing and analytical company focused on plant-based therapeutics, will soon be awarded one of the first federal production licenses from the Drug Enforcement Administration (DEA) to produce clean, consistent and compliant cannabis for federally approved researchers across the United States. BRC will be among a select few Read the full article...
http://dlvr.it/RzmvNd